Just the beginning of upgrades......ConjuChem (CJC - TSX)
00:00 EST Friday, April 02, 2004
$14.49, up 65 cents
The stock of Montreal-based ConjuChem Inc. also hit a 52-week high after Dlouhy Merchant raised its 12-month target price to $20 from $15. The stock's 52-week low is 35 cents. Analyst Doug Loe said the drug developer is expected to float a cross-border financing to coincide with a Nasdaq listing by midyear, and land a Big Pharma partnership deal for its Type 2 diabetes drug.
© The Globe and Mail